Financial Statements — ELVA
Balance Sheet
(in millions USD)| Metric | Q3
2025 |
|---|
| Cash & Equivalents | 1.29 |
| Inventory | 12.10 |
| Total Current Assets | 42.29 |
| Total Non-current Assets | 11.59 |
| Total Assets | 53.87 |
| Total Current Liabilities | 10.49 |
| Total Non-current Liabilities | 21.05 |
| Total Liabilities* | 31.54 |
| Retained Earnings | (127.93) |
| Total Stockholder Equity | 22.33 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q3
2025 |
|---|
| Total Revenue | 17.13 |
| Cost of Revenue* | 11.86 |
| Gross Profit | 5.28 |
| Research & Development | 1.17 |
| Selling, General & Admin | 0.63 |
| Total Operating Expenses | 3.32 |
| Interest Expense | 0.00 |
| Net Income | 0.91 |
| Basic EPS | 0.02 |
| Diluted EPS | 0.02 |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q3
2025 |
|---|
| Operating Cash Flow | (7.31) |
| Investing Cash Flow | (2.59) |
| Financing Cash Flow | 10.53 |
